par Decaux, Guy ;Gankam Kengne, Fabrice ;Couturier, Bruno ;Vandergheynst, Frederic ;Musch, Wim;Soupart, Alain
Référence Journal of Clinical Medicine, 3, 3, page (1043-1049)
Publication Publié, 2014-09
Référence Journal of Clinical Medicine, 3, 3, page (1043-1049)
Publication Publié, 2014-09
Article révisé par les pairs
Résumé : | Oral urea has been used in the past to treat various diseases like gastric ulcers, liver metastases, sickle cell disease, heart failure, brain oedema, glaucoma, Meniere disease, etc. We have demonstrated for years, the efficacy of urea to treat euvolemic (SIADH) or hypervolemic hyponatremia. We briefly describe the indications of urea use in symptomatic and paucisymptomatic hyponatremic patients. Urea is a non-toxic, cheap product, and protects against osmotic demyelinating syndrome (ODS) in experimental studies. Prospective studies showing the benefit to treat mild chronic hyponatremia due to SIADH and comparing water restriction, urea, high ceiling diuretics, and antivasopressin antagonist antagonist should be done. |